Diversity in Clinical Trials In support of the FDASIA Section 907 Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data, OMH will conduct outreach to minority audiences to increase awareness about the importance of diverse participation in clinical trials.
FY 17-18 Diversity in Clinical TrialsCOMPLETECOMPLETEA. Update website with information about clinical trial diversity9/30/2018Completed9/30/2018B. Develop health education materials about clinical trial diversity for minorities9/30/2018Completed9/30/2018C. Develop and disseminate multi-media campaign about clinical diversity9/30/2018Completed9/30/2018
FY 2019 Diversity in Clinical TrialsCOMPLETECOMPLETEA. Update website with information about clinical trial diversity9/30/2019Completed9/30/2019B. Conduct Health Education Campaigns in other languages9/30/2019Completed9/30/2019C. Develop and disseminate multi-media campaign about clinical diversity.9/30/2019Completed9/30/2019
FY 2020 Diversity in Clinical TrialsCOMPLETEDCOMPLETEDA. Update website with information about clinical trial diversity9/30/2020Completed9/30/2020B. Develop health education materials about clinical trial diversity for minorities9/30/2020Completed9/30/2020C. Promote multi-media campaign about clinical diversity.9/30/2020Completed9/30/2020
FY 2021 Diversity in Clinical TrialsCOMPLETEDCOMPLETEDA. Update website with information about clinical trial diversity9/30/2021Completed9/30/2021B. Develop health education materials about clinical trial diversity for minorities9/30/2021Completed9/30/2021C. Develop and disseminate multi-media campaign about clinical diversity.9/30/2021Completed9/30/2021
https://www.fda.gov/about-fda/fda-track-agency-wide-program-performance/fda-track-office-chief-scientist-dashboardFDA-TRACK OC Office of the Chief Scientist Dashboard